SHARE
LDEO_ham_menu_bw.svg
HICCC_AR23_round_menu_blue_line.svg
HICCC_23_name_bar_in_diagonal.svg
RESEARCH SNAPSHOT
The Herbert Irving Comprehensive Cancer Center (HICCC) has a wide-ranging portfolio of basic, clinical, and population science research supported by funding from government, foundation, and industry sources.
PROGRAM MEMBERS OF THE HICCC
The more than 250 researchers and physicians that are members of the HICCC are dedicated to understanding the complex biology behind cancer, from before it begins to its evolution and spread. The HICCC has four formal research programs that organize our membership.

TOTAL CLINICAL TRIAL ENROLLMENTS IN 2022

61
Cancer Genomics and Epigenomics
80
Tumor Biology and Microenvironment
49
Precision Oncology and Systems Biology
64
Cancer Population Science
TOTAL CLINICAL TRIAL ENROLLMENTS IN 2022

ACTIVE FUNDED PROJECTS IN 2023

Research Funding By Source Grand Total (All Projects)
$108,993,356
Government $79,597,536
73%
Foundations & Associations
$10,366,801
10%
Industry
$19,029,018
17%
Research Projects by
Funding Source Grand Total (All Projects)
943
Government
504
53%
Foundations & Associations
99
11%
Industry
340
36%
ACTIVE FUNDED PROJECTS IN 2022
RESEARCH FUNDING BY SOURCE GRAND TOTAL (ALL PROJECTS) $108,993,356
Government
$79,597,536 73%
Foundations & Associations
$10,366,801 10%
Industry
$19,029,018 17%
RESEARCH PROJECTS BY FUNDING SOURCE GRAND TOTAL (ALL PROJECTS) 943
Government
504 53%
Foundations & Associations
99 11%
Industry
340 36%

PROGRAM MEMBERS OF THE HICCC

The more than 250 researchers and physicians that are members of the HICCC are dedicated to understanding the complex biology behind cancer, from before it begins to its evolution and spread. The HICCC has four formal research programs that organize our membership.
61
Cancer Genomics and Epigenomics
80
Tumor Biology and
Microenvironment
49
Precision Oncology and Systems Biology
64
Cancer Population
Science
“Icon to go up on page"